申请人:Karp Mitchell Gary
公开号:US20060223863A1
公开(公告)日:2006-10-05
In accordance with the present invention, compounds that inhibit viral replication, preferably Hepatitis C Virus (HCV) replication, have been identified, and methods for their use provided. In one aspect of the invention, compounds useful in the treatment or prevention of a viral infection are provided. In another aspect of the invention, compounds useful in the treatment or prevention of HCV infection are provided.
根据本发明,已经确定了抑制病毒复制的化合物,优选为丙型肝炎病毒(HCV)复制,并提供了其使用方法。在本发明的一个方面,提供了用于治疗或预防病毒感染的化合物。在本发明的另一个方面,提供了用于治疗或预防HCV感染的化合物。